Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 1, 2007, Pages 51-59

  Sugimoto, Mitsushige ^a   Furuta, Takahisa ^a   Shirai, Naohito ^a   Nakamura, Akiko ^a   Xiao, Fang ^a   Kajimura, Masayoshi ^a   Sugimura, Haruhiko ^a   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine polymorphism; Gastric cancer; Helicobacter pylori; Interleukin 1 ; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DUODENUM ULCER; FEMALE; GASTRITIS; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER PYLORI; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH CANCER;

EID: 33845646828     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04442.x     Document Type: Article

References (51)

1. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001; 345: 784-9.
2. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52.
3. Wotherspoon AC, Doglioni C, de Boni M et al. Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet 1994; 343: 1503.
4. Parsonnet J, Harris RA, Hack HM et al. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348: 150-4.
5. Furuta T, Ohashi K, Kamata T et al. Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann. Intern. Med. 1998; 129: 1027-30.
6. Wang M, Furuta T, Takashima M et al. Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. J. Gastroenterol. 1999; 34 (Suppl 11): 10-17.
7. Yamaoka Y, Kita M, Kodama T et al. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997; 41: 442-51.
8. Wolfe MM, Nompleggi DJ. Cytokine inhibition of gastric acid secretion - a little goes a long way. Gastroenterology 1992; 102: 2177-8.
9. Kondo S, Shinomura Y, Kanayama S et al. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am. J. Physiol. 1994; 267: G966-71.
10. Takashima M, Furuta T, Hanai H et al. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001; 48: 765-73.
11. Furuta T, Baba S, Takashima M et al. Effect of Helicobacter pylori infection on gastric juice pH. Scand. J. Gastroenterol. 1998; 33: 357-63.
12. Furuta T, El-Omar EM, Xiao F et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92-105.
13. Watanabe T, Higuchi K, Tominaga K et al. Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta. Gut 2001; 48: 774-81.
14. Watanabe T, Arakawa T, Fukuda T et al. Role of neutrophils in a rat model of gastric ulcer recurrence caused by interleukin-1 beta. Am. J. Pathol. 1997; 150: 971-9.
15. Uedo N, Tatsuta M, Iishi H et al. Enhancement by interleukin-1 beta of gastric carcinogenesis induced by N-methyl-N-nitro-N-nitrosoguanidine in Wistar rats: a possible mechanism for Helicobacter pylori-associated gastric carcinogenesis. Cancer Lett. 2003; 198: 161-8.
16. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
17. Hwang IR, Kodama T, Kikuchi S et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-803.
18. Wallace JL, Cucala M, Mugridge K et al. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am. J. Physiol. 1991; 261: G559-64.
19. Zeng ZR, Hu PJ, Hu S et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 2003; 52: 1684-9.
20. Figueiredo C, Machado JC, Pharoah P et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 2002; 94: 1680-7.
21. Machado JC, Figueiredo C, Canedo P et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-71.
22. Machado JC, Pharoah P, Sousa S et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823-9.
23. Garcia-Gonzalez MA, Lanas A, Santolaria S et al. The polymorphic IL-1β and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin. Exp. Immunol. 2001; 125: 368-75.
24. El-Omar EM, Rabkin CS, Gammon MD et al. Increased risk of non-cardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-201.
25. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 1997; 34: 391-9.
26. Yen JH, Chen CJ, Tsai WC et al. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J. Rheumatol. 2001; 28: 1788-92.
27. Negoro K, Kinouchi Y, Hiwatashi N et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999; 117: 1062-8.
28. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF) -alpha gene in Japanese. Tissue Antigens 1998; 51: 605-12.
29. Soga Y, Nishimura F, Ohyama H et al. Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863-857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J. Clin. Periodontol. 2003; 30: 524-31.
30. Adachi K, Kawamura A, Ono M et al. Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection. J. Gastroenterol. 2002; 37: 703-8.
31. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histoclinical classification. Acta Pathol. Microbiol. Scand. 1965; 64: 31-49.
32. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand. J. Immunol. 1998; 47: 195-8.
33. Grove J, Daly AK, Bassendine MF et al. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997; 26: 143-6.
34. Ishiguro A, Kubota T, Soya Y et al. High-throughput detection of multiple genetic polymorphisms influencing drug metabolism with mismatch primers in allele-specific polymerase chain reaction. Anal Biochem. 2005; 337: 256-61.
35. Ohyama I, Ohmiya N, Niwa Y et al. The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur. J. Gastroenterol. Hepatol. 2004; 16: 693-700.
36. Hamajima N, Shibata A, Katsuda N et al. Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes. Gastric Cancer 2003; 6: 230-6.
37. El-Omar EM, Carrington M, Chow WH et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001; 412: 99.
38. Hamajima N, Matsuo K, Saito T et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn. J. Cancer Res. 2001; 92: 383-9.
39. Furuta T, Shirai N, Takashima M et al. Effect of genotypic differences in interleukin-1 beta on gastric acid secretion in Japanese patients infected with Helicobacter pylori. Am. J. Med. 2002; 112: 141-3.
40. Zambon CF, Basso D, Navaglia F et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005; 29: 141-52.
41. Lee SG, Kim B, Yook JH et al. TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine 2004; 28: 75-82.
42. Kato S, Onda M, Yamada S et al. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J. Gastroenterol. 2001; 36: 696-9.
43. Matsukura N, Yamada S, Kato S et al. Genetic differences in interleukin-1 betapolymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J. Exp. Clin. Cancer Res. 2003; 22: 47-55.
44. Chang YT, Wu MS, Shun CT et al. Association of polymorphisms of interleukin-1 beta gene and Helicobacter pylori infection with the risk of gastric ulcer. Hepatogastroenterology 2002; 49: 1474-6.
45. Lee KA, Ki CS, Kim HJ et al. Novel interleukin 1B polymorphism increased the risk of gastric cancer in Korean populations. J Gastroenterol. 2004; 39: 429-33.
46. Lee SG, Kim B, Choi W et al. Lack of association between proinflammatory genotypes of the interleukin-1 (IL-1B -31 C/+ and IL-1RN *2/*2) and gastric cancer/duodenal ulcer in Korean population. Cytokine 2003; 21: 167-71.
47. Yang J, Hu Z, Xu Y et al. Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett. 2004; 215: 191-8.
48. He X, Jiang L, Fu B et al. Relationship between interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms and susceptibility to gastric cancer. Zhonghua Yi Xue Za Zhi 2002; 82: 685-8.
49. Ransjo M, Marklund M, Persson M et al. Synergistic interactions of bradykinin, thrombin, interleukin 1 and tumor necrosis factor on prostanoid biosynthesis in human periodontal-ligament cells. Arch. Oral Biol. 1998; 43: 253-60.
50. Lindstrom E, Lerner UH, Hakanson R. Isolated rat stomach ECL cells generate prostaglandin E (2) in response to interleukin-1 beta, tumor necrosis factor-alpha and bradykinin. Eur. J. Pharmacol. 2001; 416: 255-63.
51. Garcia-Gonzalez MA, Lanas A, Savelkoul PH et al. Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin. Exp. Immunol. 2003; 134: 525-31.